Investors
News & Events
Contact Us
Home
Who We Are
Company Overview
Management Team
Board of Directors
Partners
Pipeline
Clinical Programs
IRAK1/4
RIPK1
Partnered Programs
Clinical Trials
Investigator Sponsored Research
Expanded Access Policy
Products
Join Our Team
Life at Rigel
Our Values
Benefits
Current Openings
Investors
News & Events
Contact Us
All SEC Filings
Investors
Investors
Overview
News & Events
Press Releases
Events & Presentations
Email Alerts
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
FAQ
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Analyst Coverage
Governance
Management Team
Board of Directors
Board Committees
Governance Documents
ESG
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-K405
10-Q
10-Q/A
3
3/A
4
4/A
424A
424B2
424B3
424B4
424B5
5
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFR14A
EFFECT
FWP
POS AM
POSASR
PRE 14A
REGDEX
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Date
Form
Description
PDF
XBRL
Pages
02/04/00
S-1
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-4.4
EX-4.5
EX-4.6
EX-4.7
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.12
EX-23.1
EX-27.1
357
Previous
1…
125
126
127
128
129
130
131
132
133
134
Email Alerts
RSS News Feed